1. Home
  2. CGEM vs ASTL Comparison

CGEM vs ASTL Comparison

Compare CGEM & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • ASTL
  • Stock Information
  • Founded
  • CGEM 2016
  • ASTL 1902
  • Country
  • CGEM United States
  • ASTL Canada
  • Employees
  • CGEM N/A
  • ASTL N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • ASTL Steel/Iron Ore
  • Sector
  • CGEM Health Care
  • ASTL Industrials
  • Exchange
  • CGEM Nasdaq
  • ASTL Nasdaq
  • Market Cap
  • CGEM 490.3M
  • ASTL 532.0M
  • IPO Year
  • CGEM 2021
  • ASTL N/A
  • Fundamental
  • Price
  • CGEM $7.54
  • ASTL $5.98
  • Analyst Decision
  • CGEM Strong Buy
  • ASTL
  • Analyst Count
  • CGEM 4
  • ASTL 0
  • Target Price
  • CGEM $33.50
  • ASTL N/A
  • AVG Volume (30 Days)
  • CGEM 457.5K
  • ASTL 892.5K
  • Earning Date
  • CGEM 05-08-2025
  • ASTL 06-20-2025
  • Dividend Yield
  • CGEM N/A
  • ASTL 3.34%
  • EPS Growth
  • CGEM N/A
  • ASTL N/A
  • EPS
  • CGEM N/A
  • ASTL N/A
  • Revenue
  • CGEM N/A
  • ASTL $1,635,857,227.00
  • Revenue This Year
  • CGEM N/A
  • ASTL $9.58
  • Revenue Next Year
  • CGEM N/A
  • ASTL $13.20
  • P/E Ratio
  • CGEM N/A
  • ASTL N/A
  • Revenue Growth
  • CGEM N/A
  • ASTL N/A
  • 52 Week Low
  • CGEM $6.85
  • ASTL $4.17
  • 52 Week High
  • CGEM $30.19
  • ASTL $12.14
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.51
  • ASTL 61.16
  • Support Level
  • CGEM $7.50
  • ASTL $5.24
  • Resistance Level
  • CGEM $8.97
  • ASTL $5.82
  • Average True Range (ATR)
  • CGEM 0.48
  • ASTL 0.35
  • MACD
  • CGEM -0.04
  • ASTL 0.15
  • Stochastic Oscillator
  • CGEM 2.72
  • ASTL 96.61

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: